Dr. Sofie Ryckx
ActiveSummary
Dr. Sofie Ryckx has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €261k and a net result of €114k. Equity is growing by ~49.7% per year across the filed fiscal years. Its solvency ranks better than 91% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 9.53 against 14.95 in 2023; short-term debt: 5.1% and cash: 47.1% of total assets), and 5.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
94.9%
Return on assets
41.5%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
36 d early
2022
32 d early
2021
32 d early
2020
32 d early
2019
31 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€261k▲ 20.4%
2023 · €217k
2018: €10k
2019: €54k
2020: €77k
2021: €84k
2022: €146k
2023: €217k
2018 → 2024
Total assets
€275k▲ 21.7%
2023 · €226k
2018: €20k
2019: €55k
2020: €80k
2021: €86k
2022: €148k
2023: €226k
2018 → 2024
Net result
€114k▲ 76.6%
2023 · €65k
2018: €-3k
2019: €44k
2020: €24k
2021: €71k
2022: €63k
2023: €65k
2018 → 2024
Working capital
€119k▼ 7.7%
2023 · €129k
2018: €6k
2019: €51k
2020: €75k
2021: €74k
2022: €134k
2023: €129k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€77k-€84k▲ 8.0%€146k▲ 74.9%€217k▲ 48.5%€261k▲ 20.4%
Operating result€30k-€90k▲ 198%€80k▼ 11.5%€82k▲ 3.3%€146k▲ 77.5%
Net result€24k-€71k▲ 202%€63k▼ 12.1%€65k▲ 3.4%€114k▲ 76.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 77% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €275k
Fixed assets
€142k ▲ 61.4%
Current assets
€133k ▼ 3.7%
Equity and liabilities €275k
Equity
€261k ▲ 20.4%
Debt
€14k ▲ 51.0%
Debt's share of the balance-sheet total rises from 4.1% to 5.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€153k▲
2023 · €86k
Cash flow
€121k▲
2023 · €69k
Current ratio
9.53▼
2023 · 14.95
Debt to equity
0.05▲
2023 · 0.04
ROE
43.7%▲
2023 · 29.8%
ROA
41.5%▲
2023 · 28.6%
Interest coverage
439.03▼
2023 · 1920.83
Debt ≤ 1 year
€14k▲
2023 · €9k
Income taxes
€33k▲
2023 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 44 lines
Balance sheet
Code20232024
Assets
Total assets20/58€226k€275k▲
Fixed assets21/28€88k€142k▲
Tangible fixed assets22/27€25k€55k▲
Plant, machinery and equipment23€1k€2k▲
Furniture and vehicles24€4k€7k▲
Other tangible fixed assets26€20k€46k▲
Financial fixed assets28€63k€87k▲
Current assets29/58€138k€133k▼
Amounts receivable within one year40/41€3k-
Other amounts receivable41€3k-
Cash at bank and in hand54/58€132k€130k▼
Deferred charges and accrued income490/1€3k€3k▼
Equity and liabilities
Total equity and liabilities10/49€226k€275k▲
Equity10/15€217k€261k▲
Contributions10/11€19k€19k=
Reserves13€198k€242k▲
Distributable reserves133€198k€242k▲
Profit (loss) carried forward14€402€691▲
Amounts payable17/49€9k€14k▲
Amounts payable within one year42/48€9k€14k▲
Trade debts44€1k€403▼
Suppliers440/4€1k€403▼
Taxes, remuneration and social security45€8k€14k▲
Taxes450/3-€9k
Remuneration and social security454/9€8k€5k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€7k▲
Other operating charges640/8€1k€601▼
Gross operating margin9900€87k€154k▲
Operating profit (loss)9901€82k€146k▲
Financial income75/76B-€1k
Recurring financial income75-€1k
Financial charges65/66B€45€348▲
Recurring financial charges65€45€348▲
Profit (loss) for the period before taxes9903€82k€147k▲
Income taxes67/77€18k€33k▲
Profit (loss) for the period9904€65k€114k▲
Profit (loss) for the period to be appropriated9905€65k€114k▲
Appropriation of the result
Profit (loss) to be appropriated9906€65k€115k▲
Profit (loss) brought forward from the previous period14P€697€402▼
Transfer from equity791/2-€70k
Transfer to equity691/2€65k€114k▲
To other reserves6921€65k€114k▲
Profit to be distributed694/7-€70k
Return on contributions (dividend)694-€70k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €114k ▲76.6%
Operating result €146k, net result €114k, both a record.
25-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €217k ▲48.5%
5 profitable years in a row build equity to €217k.
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100kEq €146k ▲74.9%
4 profitable years in a row build equity to €146k.
29-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
29-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Back to profitnet €44k
Net result €44k after one loss-making year.
31-12
Financial
Liquidity times 24current ratio 38.35
Current ratio from 1.57 to 38.35; short-term debt falls from €10k to €1k.
28-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Temse · 1 establishment unit since 2018
Ground area
502 m²
Building footprint
153 m²
Volume, LiDAR
878 m³
Parcel 46025B0782/00R000, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Dr. Sofie Ryckx
since 20182.280.339.346
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46025B0782/00R000 | Flanders | 502 m² | 1 · 152 m² | 9.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 900 EUR awarded · 900 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 900 EUR | 900 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
ghall_neuroch
BE 1002.856.670
Gent · Eq €261,274
Dr. Charline Wehlou - Klinisch biologe
BE 0727.398.941
Sint-Martens-Latem · Eq €261,384
Dokter Chris Sprengers
BE 0439.788.991
Gent · Eq €261,037
DOKTER NATASCHA BOSSUYT
BE 0822.269.196
Geraardsbergen · Eq €261,014
DOCTEUR HUBERT NICOLAS
BE 0898.813.579
Wanze · Eq €261,623
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 6,681 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-10-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.